446 related articles for article (PubMed ID: 8646567)
1. Effects of luteinizing-hormone-releasing hormone, alpha-melanocyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release.
Karanth S; Lyson K; Aguila MC; McCann SM
Neuroimmunomodulation; 1995; 2(3):166-73. PubMed ID: 8646567
[TBL] [Abstract][Full Text] [Related]
2. Involvement of arachidonic acid cascade pathways in interleukin-6-stimulated corticotropin-releasing factor release in vitro.
Lyson K; McCann SM
Neuroendocrinology; 1992 Jun; 55(6):708-13. PubMed ID: 1630586
[TBL] [Abstract][Full Text] [Related]
3. Alpha-melanocyte-stimulating hormone inhibits corticotropin-releasing factor release by blocking protein kinase C.
Lyson K; McCann SM
Neuroimmunomodulation; 1994; 1(3):153-8. PubMed ID: 7489328
[TBL] [Abstract][Full Text] [Related]
4. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami.
Karanth S; Lyson K; McCann SM
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3383-7. PubMed ID: 8475085
[TBL] [Abstract][Full Text] [Related]
5. Alpha-melanocyte-stimulating hormone abolishes IL-1- and IL-6-induced corticotropin-releasing factor release from the hypothalamus in vitro.
Lyson K; McCann SM
Neuroendocrinology; 1993 Aug; 58(2):191-5. PubMed ID: 8264864
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids.
Cambronero JC; Rivas FJ; Borrell J; Guaza C
Endocrinology; 1992 Aug; 131(2):677-83. PubMed ID: 1639014
[TBL] [Abstract][Full Text] [Related]
7. Ethanol inhibits luteinizing hormone-releasing hormone (LHRH) secretion by blocking the response of LHRH neuronal terminals to nitric oxide.
Canteros G; Rettori V; Franchi A; Genaro A; Cebral E; Faletti A; Gimeno M; McCann SM
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3416-20. PubMed ID: 7724577
[TBL] [Abstract][Full Text] [Related]
8. Role of nitric oxide and alcohol on gonadotropin release in vitro and in vivo.
Rettori V; McCann SM
Ann N Y Acad Sci; 1998 May; 840():185-93. PubMed ID: 9629250
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of action of alcohol to suppress gonadotropin secretion.
Rettori V; McCann SM
Mol Psychiatry; 1997 Sep; 2(5):350-4. PubMed ID: 9322222
[TBL] [Abstract][Full Text] [Related]
10. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
Rivest S; Plotsky PM; Rivier C
Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
[TBL] [Abstract][Full Text] [Related]
11. Endogenous opioid peptides mediate the interleukin-1-induced inhibition of the release of luteinizing hormone (LH)-releasing hormone and LH.
Kalra PS; Fuentes M; Sahu A; Kalra SP
Endocrinology; 1990 Nov; 127(5):2381-6. PubMed ID: 2226323
[TBL] [Abstract][Full Text] [Related]
12. Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus.
Karanth S; Lyson K; McCann SM
Neuroimmunomodulation; 1999; 6(3):168-74. PubMed ID: 10213914
[TBL] [Abstract][Full Text] [Related]
13. beta-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release.
Faletti AG; Mastronardi CA; Lomniczi A; Seilicovich A; Gimeno M; McCann SM; Rettori V
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1722-6. PubMed ID: 9990091
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in the neuroendocrine responses to cytokines.
McCann SM; Kimura M; Karanth S; Yu WH; Rettori V
Ann N Y Acad Sci; 1998 May; 840():174-84. PubMed ID: 9629249
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.
Raber J; Koob GF; Bloom FE
J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199
[TBL] [Abstract][Full Text] [Related]
16. Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications.
Calogero AE; Gallucci WT; Gold PW; Chrousos GP
J Clin Invest; 1988 Sep; 82(3):767-74. PubMed ID: 2843570
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony stimulating factor suppresses LHRH release by inhibition of nitric oxide synthase and stimulation of gamma-aminobutyric acid release.
Kimura M; Yu WH; Rettori V; McCann SM
Neuroimmunomodulation; 1997; 4(5-6):237-43. PubMed ID: 9650816
[TBL] [Abstract][Full Text] [Related]
18. Alpha-melanocyte-stimulating hormone antagonizes the neuroendocrine effects of corticotropin-releasing factor and interleukin-1 alpha in the primate.
Shalts E; Feng YJ; Ferin M; Wardlaw SL
Endocrinology; 1992 Jul; 131(1):132-8. PubMed ID: 1319315
[TBL] [Abstract][Full Text] [Related]
19. Differential in vitro stimulation by naloxone and K+ of luteinizing hormone-releasing hormone and catecholamine release from the hypothalami of intact and castrated rats.
Kalra PS; Crowley WR; Kalra SP
Endocrinology; 1987 Jan; 120(1):178-85. PubMed ID: 3536452
[TBL] [Abstract][Full Text] [Related]
20. Stimulation and inhibition of corticotrophin releasing factor secretion by beta endorphin.
Buckingham JC
Neuroendocrinology; 1986; 42(2):148-52. PubMed ID: 2936971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
